在Loeys-Dietz综合征中肺血管异常和自发性肺胸部
Wataru Arai1, Mitsuko Furuya2, Yukio Nakatani3
1Department of Respiratory Surgery, Sapporo City General Hospital, Sapporo, Japan.
Pathology international
|January 6, 2026
概括
洛伊斯-迪茨综合征 (LDS) 肺部病理表明毛细血管和血管异常,可能导致自发性肺胸. 这项研究详细介绍了LDS患者这些独特的肺血管变化.
科学领域:
- 病理学 病理学 病理学
- 遗传学 遗传学 是一个
- 肺部病理学 肺部病理学
背景情况:
- 洛伊斯-迪茨综合征 (LDS) 与马方综合征和血管埃勒斯-丹洛斯综合征有共同的症状,包括大动脉动脉瘤和肺胸部.
- 在LDS肺部病理学是不太了解,不像在MFS和vEDS.
研究的目的:
- 描述Loeys-Dietz综合征中肺血管异常和肺胸部的组织病理特征.
主要方法:
- 从一个患有洛伊斯-迪茨综合征的患者手术切除的肺组织的组织病理学检查.
- 基因分析确定了一个TGFBR2变体.
主要成果:
- 肺部表现出突破的丸子,肺气,以及扩张的,扭曲的毛细血管的扩散,类似于肺毛细血管血瘤.
- 肺动脉和静脉表现出不规则的扩张和扭曲,有碎片化的弹性纤维.
- 在空气空间中观察到含有血红素的巨细胞.
结论:
- 异常的TGF-β信号传递和被破坏的矩阵形成可能会导致LDS肺部的血管和肺变化.
- 这些发现阐明了与Loeys-Dietz综合征和肺部胸部相关的肺病理.
更多相关视频
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
51.9K
08:34Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
7.6K
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
562
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
562
Pulmonary Embolism I: Introduction
500
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
500
Pneumothorax-I
1.1K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.1K
Pneumothorax-II
884
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
884
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
